SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000930413-18-000384
Filing Date
2018-02-14
Accepted
2018-02-13 18:40:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 c90497_sch13g.htm SC 13G 37076
  Complete submission text file 0000930413-18-000384.txt   38594
Mailing Address SUITE 300, 5 PLACE VILLE MARIE MONTREAL A8 H3B 5E7
Business Address SUITE 300, 5 PLACE VILLE MARIE MONTREAL A8 H3B 5E7 514-283-0869
BDC CAPITAL INC. (Filed by) CIK: 0001430885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: SC 13G

Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Subject) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90071 | Film No.: 18605890
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences